sucujovide.wordpress.com
The money was granted in collaboration withthe U.S. Army Medicalo Research and Materiel Commancd and the throughthe Ft. Detricik Technology Transfer Initiative. The purpose of the technology transfer prograkm is to raise awareness of new and developing technologies and funding them to transition as viabls projectsfor follow-on funding in the market Each company that received funding was awardedx approximately $50,000 between March 2008 and May 2009, makingb up the initiative’s second round of financial awards since its $750,000 program extension. The funds for the program’s second phas e were secured by Sen. Barbara Mikulski, D-Md., and Rep. Roscoe G. Bartlett, R-Md.
“The [Ft. Detricjk Technology Transfer Initiative] program is enablinh area businesses to harness the technologieds being developed at Fort Detrick and apply them to thecommerciakl sector,” said Mikulski. “This will lead to new productas that have the power to creatse jobs andsave lives.” Mikulski announcecd the first phase of the tech transfet program in March 2005 when 11 companiesx received funding.
in Rockville: The compan y is developing a health care technology calledmiTag system, which is a scalabl wireless sensor solution for improving patient in Frederick: The company is developing a technology callesd the GeNova Screen to identify, isolate, and produce antibody-like molecules. in Rockville: The company is developing an on-demand biotech products including a combination vaccine against plague and BioAssay Works LLC in The company is developinga lateral-flow visual diagnostic test to detecg and differentiate single sample multiple pathogenic including variola, vaccinia, and monkeypox.
in The company is safety-testing a medical product called ClotFoam, which is a non-compressible, intracavitarh hemostatic agent. CynerGene IDMP in The companyis developing, validating and implementin g a supplemental diagnosis of HIV, and Dengue using its Infectious Disease Multiplex Panel which could allow for creation of LLC in Baltimore: The companhy is developing required components and systenm framework to enable conversational interfaces for telemedicine Such tools would allow professional medics to use gesture, and other human-- computer interactionds to access and document information in electronic medical records.
in The company is developing technology to preservr mammalian cells in driedd format that can easilybe re-hydrated for a variety of uses. LLC in The company is evaluating the effect of Imagilin patenteed probiotics as a food supplement to enhance the immune responsivenessd of guinea pigs upon immunization or challenge with virulent The evaluation will suggest the ability of Imagilij patented probiotics to enhance the immunization of a in Baltimore: The company is developing micropatterned substratesw for viral infectivity assays. Juxtopia in Baltimore: The companh is customizing its Wearable Assistance and SituationalAwareness (WASA) goggles and service to allow U.S.
Army combat mediczs to access and document information to electricalk medical recordsvia hands-free voice-requests and in Baltimore: The company is developing cell therapies to treat brain and spinakl cord injuries.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment